Aberrant Telomere Length in Circulating Cell-Free DNA as Possible Blood Biomarker with High Diagnostic Performance in Endometrial Cancer-Reference-Cited by-同舟云学术

Aberrant Telomere Length in Circulating Cell-Free DNA as Possible Blood Biomarker with High Diagnostic Performance in Endometrial Cancer

Published:2020-05-27 Issue:4 Volume:26 Page:2281-2289
ISSN:1219-4956
Container-title:Pathology & Oncology Research
language:en
Short-container-title:Pathol. Oncol. Res.

Author:

Benati Marco,Montagnana Martina,Danese Elisa,Mazzon Martina,Paviati Elisa,Garzon Simone^ORCID,Laganà Antonio Simone,Casarin Jvan,Giudici Silvia,Raffaelli Ricciarda,Ghezzi Fabio,Franchi Massimo,Lippi Giuseppe

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12253-020-00819-x.pdf

Reference68 articles.

1. Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, Marth C, Nout R, Querleu D, Mirza MR, Sessa C, ESMO-ESGO-ESTRO Endometrial Consensus Conference Working Group (2016) ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Int J Gynecol Cancer 26:2–30. https://doi.org/10.1097/IGC.0000000000000609

2. Yeramian A, Moreno-Bueno G, Dolcet X, Catasus L, Abal M, Colas E, Reventos J, Palacios J, Prat J, Matias-Guiu X (2013) Endometrial carcinoma: molecular alterations involved in tumor development and progression. Oncogene 32:403–413. https://doi.org/10.1038/onc.2012.76

3. Montagnana M, Lippi G, Ruzzenente O, Bresciani V, Danese E, Scevarolli S, Salvagno GL, Giudici S, Franchi M, Guidi GC (2009) The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass. J Clin Lab Anal 23:331–335. https://doi.org/10.1002/jcla.20340

4. Montagnana M, Benati M, Danese E, Giudici S, Perfranceschi M, Ruzzenenete O, Salvagno GL, Bassi A, Gelati M, Paviati E, Guidi GC, Franchi M, Lippi G (2017) Aberrant MicroRNA expression in patients with endometrial cancer. Int J Gynecol Cancer 27:459–466. https://doi.org/10.1097/IGC.0000000000000913

5. Benati M, Montagnana M, Danese E, Paviati E, Giudici S, Franchi M, Lippi G (2017) Evaluation of mir-203 expression levels and DNA promoter methylation status in serum of patients with endometrial cancer. Clin Lab 63:1675–1681. https://doi.org/10.7754/Clin.Lab.2017.170421

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Clinicopathological Features and Prognoses of Lower Uterine Segment Cancer: A Retrospective, Single-Center Cohort Study;International Journal of Women's Health;2024-08

2. Telomeres and telomerase in endometrial cancer and hyperplasia;Archives of Medical Science;2024-03-30

3. Recent management of endometrial cancer: a narrative review of the literature;Frontiers in Medicine;2024-01-03

4. The Diagnostic, Prognostic, and Therapeutic Potential of Cell-Free DNA with a Special Focus on COVID-19 and Other Viral Infections;International Journal of Molecular Sciences;2023-09-15

5. Timeliness of diagnostic evaluation for postmenopausal bleeding: A retrospective cohort study using claims data;PLOS ONE;2023-09-08